ACOTEC SCIEN.H. DL-00001 (7W3) — Capital Reinvestment Ratio

Latest as of December 2025: 0.54x

ACOTEC SCIEN.H. DL-00001 (7W3) has a Capital Reinvestment Ratio of 0.54x as of December 2025, meaning it reinvests 1% of its operating cash flow (€150.27 Million) in capital expenditures (€81.15 Million). Check 7W3 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.54x
Capex / Operating Cash Flow

Operating Cash Flow

€150.27 Million
EUR

Capital Expenditures

€81.15 Million
EUR

Data as of

Dec 2025
Most recent filing

ACOTEC SCIEN.H. DL-00001 Capital Reinvestment Ratio (2024–2025)

This chart tracks ACOTEC SCIEN.H. DL-00001's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does ACOTEC SCIEN.H. DL-00001 generate cash.

Annual Capital Reinvestment Ratio for ACOTEC SCIEN.H. DL-00001 (2024–2025)

Year-by-year Capital Reinvestment Ratio for ACOTEC SCIEN.H. DL-00001 from 2024 to 2025. See 7W3 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.54x €150.27 Million €81.15 Million ▼ -43.1%
2024 0.95x €102.79 Million €97.48 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow